BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Shareholders Equity (Quarterly) : 2.70M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.70M |
| March 31, 2026 | -1.066M |
| December 31, 2025 | 0.895M |
| September 30, 2025 | 2.627M |
| June 30, 2025 | -1.886M |
| March 31, 2025 | -1.52M |
| December 31, 2024 | 0.837M |
| September 30, 2024 | 2.753M |
| June 30, 2024 | -1.961M |
| March 31, 2024 | -2.275M |
| December 31, 2023 | -1.603M |
| September 30, 2023 | -0.66M |
| June 30, 2023 | 1.635M |
| March 31, 2023 | 1.90M |
| December 31, 2022 | 4.892M |
| September 30, 2022 | 4.097M |
| June 30, 2022 | 6.734M |
| March 31, 2022 | 7.369M |
| December 31, 2021 | 10.38M |
| September 30, 2021 | 13.41M |
| June 30, 2021 | 15.67M |
| March 31, 2021 | 18.56M |
| December 31, 2020 | 19.18M |
| September 30, 2020 | 4.113M |
| June 30, 2020 | 7.291M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.283M |
| December 31, 2019 | 2.37M |
| September 30, 2019 | 5.194M |
| June 30, 2019 | -2.236M |
| March 31, 2019 | 0.818M |
| December 31, 2018 | 3.792M |
| September 30, 2018 | 2.944M |
| June 30, 2018 | 5.758M |
| March 31, 2018 | 8.207M |
| December 31, 2017 | 11.12M |
| September 30, 2017 | 13.78M |
| June 30, 2017 | 16.08M |
| March 31, 2017 | 18.35M |
| December 31, 2016 | |
| September 30, 2016 | 19.15M |
| June 30, 2016 | 14.02M |
| March 31, 2016 | 13.95M |
| December 31, 2015 | 13.87M |
| September 30, 2015 | 13.78M |
| June 30, 2015 | 13.69M |
| March 31, 2015 | 13.62M |
| December 31, 2014 | 13.54M |
| September 30, 2014 | 13.48M |
| June 30, 2014 | 13.44M |
| March 31, 2014 | 13.37M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -173.49M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.755M |
| Total Liabilities (Quarterly) | 2.055M |
| Debt to Equity Ratio | 0.1085 |
| Current Ratio | 2.092 |
| Net Debt Paydown Yield | 0.60% |